Toumaz to Exhibit at Embedded World 2011

ToumazToumaz, the leading provider of ultra-low energy wireless telemetry technologies for medical monitoring and internet-connected consumer devices, will be demonstrating its latest ultra-low energy wireless SoC TELRAN at Embedded World 2011 in Germany.

The Embedded World exhibition and conference takes place on 1 - 3 March 2011 at the Exhibition Centre Nürnberg Messe. Embedded World is the World's biggest exhibition of its kind and the meeting place of the international embedded community. The event showcases modern, leading-edge ideas and solutions to global challenges for which engineers and especially the developers of embedded systems bear special responsibility. The accompanying conference is the leading European event for the embedded industry and covers all fields of embedded system development. Toumaz will be exhibiting at the event for the first time and will be located at Stand 367 (Hall 12). On the show floor, attendees will be able to see demonstrations of Toumaz's innovative products, including wireless 3 axis accelerometer using the TZ1053TDK boards at 868MHz.

Toumaz has recently added to its expanding 'Connected Consumer' and Connected Healthcare product portfolio with the launch of TZ1053 TELRAN - an ultra-low energy radio for wireless sensor networks, environmental monitoring and smart metering. The portfolio also includes the SensiumTM vital signs monitoring platform, FENIX DAB+/DAB/FM CMOS RF IC and the XENIF all-in-one internet connected and broadcast audio SoC announced in September 2010.

Embedded World annually attracts 18,350 visitors from 66 countries and continues to grow each year. The event is the top worldwide platform for the industry to exchange ideas and source information at a high level.

Related news articles:

About Toumaz
Toumaz (AIM: TMZ) is pioneering low cost, ultra-low power wireless telemetry technologies for a wide range of markets including medical monitoring and internet-connected consumer devices.

Targeting the healthcare market, Toumaz's licensable smart sensor interface and transceiver platform, Sensium, is a leader in non-intrusive, real-time wireless monitoring of multiple physiological vital signs. Sensium offers the potential to transform medical monitoring and reduce the cost of healthcare by wirelessly connecting individuals to healthcare providers - simply, affordably and unobtrusively. Sensium provides the enabling technology for customers to create complete Body Area Networks based on ultra-low power, ultra-small size body-worn monitors. The Sensium system unlocks new product opportunities across a wide range of healthcare and lifestyle markets, including solutions for hospitals, care homes and telecare settings.

Toumaz also uses its ultra low power expertise to design silicon devices for wireless connectivity and internet-connected consumer products. Toumaz currently supplies FM/DAB radio chips and complete modules to market leaders in the digital radio market.

Toumaz has development centres in Oxford, UK and Taipei City, Taiwan.

Most Popular Now

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...